Literature DB >> 10766188

Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.

F Chavanne1, B C Broughton, D Pietra, T Nardo, A Browitt, A R Lehmann, M Stefanini.   

Abstract

Xeroderma pigmentosum (XP)-C is one of the more common complementation groups of XP, but causative mutations have thus far been reported for only six cases (S. G. Khan et al., J. Investig. Dermatol., 115: 791-796, 1998; L. Li et al., Nat. Genet., 5: 413-417, 1993). We have now extended this analysis by investigating the genomic and coding sequence of the XPC gene, the level of expression of the XPC transcript and the status of the XPC protein in 12 unrelated patients, including all of the 8 Italian XP-C cases identified thus far and in 13 of their parents. Eighteen mutations were detected in the open reading frame of the XPC gene, 13 of which are relevant for the pathological phenotype. The mutations are distributed across the gene, with no indication of any hotspots or founder effects. Only 1 of the 13 relevant changes is a missense mutation, the remainder causing protein truncations as a result of nonsense mutations (3), frameshifts (6), deletion (1) or splicing abnormalities (2). These findings indicate that the XPC gene is not essential for cell proliferation and viability and that mutations causing minor structural alterations may not give an XP phenotype and may not, therefore, be identified clinically. XP13PV was the only patient carrying a missense mutation (Trp690Ser on the paternal allele). This was also the only patient in which the XPC transcript was present at a normal level and the XPC protein was detectable, although at a lower than normal level. No quantitative alterations in the transcript or protein levels were detected in the XP-C heterozygous parents. However, the expression of the normal allele predominated in all of them, except the father of XP13PV, which suggests the existence of a possible mechanism for monitoring the amount of the XPC protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766188

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Diagnosis of Xeroderma Pigmentosum and Related DNA Repair-Deficient Cutaneous Diseases.

Authors:  James E Cleaver
Journal:  Curr Med Lit Dermatol       Date:  2008

2.  Xeroderma pigmentosum group C in an isolated region of Guatemala.

Authors:  James E Cleaver; Luzviminda Feeney; Jean Y Tang; Peggy Tuttle
Journal:  J Invest Dermatol       Date:  2006-09-21       Impact factor: 8.551

3.  Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC.

Authors:  Bruno M Bernardes de Jesus; Magnar Bjørås; Frédéric Coin; Jean Marc Egly
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

4.  Characterisation of novel mutations in Cockayne syndrome type A and xeroderma pigmentosum group C subjects.

Authors:  Andrew J Ridley; James Colley; David Wynford-Thomas; Christopher J Jones
Journal:  J Hum Genet       Date:  2005-03-03       Impact factor: 3.172

5.  Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.

Authors:  Christiane Kuschal; John J DiGiovanna; Sikandar G Khan; Richard A Gatti; Kenneth H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

6.  XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.

Authors:  Sikandar G Khan; Kyu-Seon Oh; Steffen Emmert; Kyoko Imoto; Deborah Tamura; John J Digiovanna; Tala Shahlavi; Najealicka Armstrong; Carl C Baker; Marcy Neuburg; Chris Zalewski; Carmen Brewer; Edythe Wiggs; Raphael Schiffmann; Kenneth H Kraemer
Journal:  DNA Repair (Amst)       Date:  2008-11-14

7.  Management of a xeroderma pigmentosum case with oral findings in a dental setup.

Authors:  Vanaja Reddy Banda; Naveen Reddy Banda; Ramesh Reddy; Praveen Banda
Journal:  BMJ Case Rep       Date:  2012-12-18

8.  XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients.

Authors:  Sikandar G Khan; Koji Yamanegi; Zhi-Ming Zheng; Jennifer Boyle; Kyoko Imoto; Kyu-Seon Oh; Carl C Baker; Engin Gozukara; Ahmet Metin; Kenneth H Kraemer
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

9.  NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites.

Authors:  Alo Ray; Keisha Milum; Aruna Battu; Gulzar Wani; Altaf A Wani
Journal:  DNA Repair (Amst)       Date:  2013-02-17

10.  Two-stage dynamic DNA quality check by xeroderma pigmentosum group C protein.

Authors:  Ulrike Camenisch; Daniel Träutlein; Flurina C Clement; Jia Fei; Alfred Leitenstorfer; Elisa Ferrando-May; Hanspeter Naegeli
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.